LENSGEN IS THE TALK OF THE TOWN @ ASCRS 2019

​LENSGEN, AN EXSIGHT VENTURES PORTFOLIO COMPANY IS THE BUZZ OF THIS YEAR’S AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGERY MEETING.

LensGen, an ExSight Ventures portfolio company, was the buzz of this year's American Society of Cataract and Refractive Surgery meeting (“ASCRS”) in San Diego. Members of the ExSight team were in the audience to hear Drs. Eric Donnenfeld, Uday Devgan, and Sumit (Sam) Garg present benefits of the company’s novel Juvene™, (the Complete Premium) IOL, and early results from the “Grail” Study. In addition to the reception LensGen had three high profile presentations during the ASCRS meetings. The first presentation by Uday Devgan, M.D. was given at Cataract/Refractive Subspecialty day. Dr. Devgan, who was also a presenter at the LensGen reception was interviewed after his talk by Healio. Dr. Devgan was the first to introduce ExSight to LensGen several years ago. 
The next presentation by Sam Garg, M.D. was made to a full audience at OIS. Dr. Garg’s talk was front-page news in Eye World ASCRS. The final presentation in this series was given by Eric Donnenfeld, M.D., to a packed house in the main ballroom at the Innovators Lecture session. Each year, ASCRS honors individuals whose innovative ideas have benefited ophthalmologist and their patients at the prestigious Innovators Lecture. Dr. Donnenfeld presented on the Juvene IOL technology and shared the early “Grail” study results. You can watch that presentation in Healio.
It was a very exciting ASCRS for LensGen! We are honored to be a small part of the LensGen story and are very optimistic about their future prospects. Ram and the rest of the LensGen team deserve praise for their dedication and execution.